Mutual Fund Ownership
Ownership as on: Fri, 13 Sep, 2024

LIC MF Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)2.97
% of AUM4.14%

UTI Healthcare Fund Regular Plan Growth

NA
Equity
Amount Invested (Cr.)16.56
% of AUM1.42%

Quant Business Cycle Fund Regular Growth

NA
Equity
Amount Invested (Cr.)13.85
% of AUM0.87%

UTI Flexi Cap Fund Regular Plan Growth

2/5
Equity
Amount Invested (Cr.)220.24
% of AUM0.81%

Nippon India Retirement Fund - Wealth Creation Scheme - Regular Growth

NA
Solutions Oriented
Amount Invested (Cr.)22.16
% of AUM0.64%

FAQs about IPCA Laboratories share price

IPCA Laboratories is trading at 1451.50 as on Thu Sep 12 2024 09:59:28. This is 1.13% upper as compared to its previous closing price of 1435.35.

The market capitalization of IPCA Laboratories is 36825.17 Cr as on Thu Sep 12 2024 09:59:28.

The average broker rating on IPCA Laboratories is Hold. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 4 analysts have given a buy rating
  • 2 analysts have given a hold rating
  • 4 analysts have given a sell rating
  • 2 analysts have given a strong sell rating

The 52 wk high for IPCA Laboratories is 1460.00 whereas the 52 wk low is 870.05

IPCA Laboratories can be analyzed on the following key metrics -

  • TTM P/E: 49.69
  • Sector P/E: 32.76
  • Dividend Yield: 0.27%
  • D/E ratio: -

IPCA Laboratories reported a net profit of 547.35 Cr in 2024.

Recommended For You
Trending Stocks
1,646.50+68.80(4.36%)
404.80+15.10(3.87%)
2,742.25+89.15(3.36%)
2,524.15-2.35 (-0.09%)
HomeMarketsPremiumInstant LoanMint Shorts